THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 31 filers reported holding THERAVANCE INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,427,000 | -10.7% | 5,500,000 | 0.0% | 0.22% | +0.5% |
Q1 2022 | $6,078,000 | -42.7% | 5,500,000 | -43.4% | 0.22% | -41.6% |
Q4 2021 | $10,607,000 | +121.2% | 9,710,000 | +117.7% | 0.38% | +84.8% |
Q3 2021 | $4,795,000 | +118.7% | 4,460,000 | +95.3% | 0.20% | +96.2% |
Q3 2020 | $2,193,000 | -32.9% | 2,284,000 | -30.5% | 0.10% | -43.8% |
Q2 2020 | $3,267,000 | +0.3% | 3,284,000 | -5.7% | 0.18% | -28.0% |
Q1 2020 | $3,257,000 | -48.0% | 3,484,000 | -44.1% | 0.26% | -25.9% |
Q4 2019 | $6,267,000 | +116.9% | 6,234,000 | +102.4% | 0.35% | +86.6% |
Q3 2019 | $2,890,000 | +33.7% | 3,080,000 | +54.0% | 0.19% | +28.3% |
Q4 2018 | $2,162,000 | -44.6% | 2,000,000 | -50.0% | 0.14% | -20.8% |
Q2 2018 | $3,902,000 | -27.2% | 4,000,000 | -20.0% | 0.18% | -31.2% |
Q1 2018 | $5,360,000 | +95.3% | 5,000,000 | +66.7% | 0.27% | +100.0% |
Q2 2017 | $2,744,000 | -42.3% | 3,000,000 | -40.0% | 0.13% | -53.3% |
Q1 2017 | $4,757,000 | +1359.2% | 5,000,000 | +1119.5% | 0.28% | +1325.0% |
Q1 2016 | $326,000 | -56.9% | 410,000 | -59.0% | 0.02% | -55.6% |
Q4 2015 | $756,000 | -42.5% | 1,000,000 | -50.0% | 0.04% | -41.6% |
Q3 2015 | $1,314,000 | -30.8% | 2,000,000 | 0.0% | 0.08% | -13.5% |
Q2 2015 | $1,900,000 | +10.4% | 2,000,000 | 0.0% | 0.09% | +2.3% |
Q1 2015 | $1,721,000 | +9.1% | 2,000,000 | 0.0% | 0.09% | +11.5% |
Q4 2014 | $1,578,000 | – | 2,000,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $1 | 0.00% |